Suven Life Sciences Limited (BOM:530239)

Suven Life Sciences Statistics

Total Valuation

BOM:530239 has a market cap or net worth of INR 30.37 billion. The enterprise value is 27.79 billion.

Market Cap	30.37B
Enterprise Value	27.79B

Important Dates

The next estimated earnings date is Thursday, January 29, 2026.

Earnings Date	Jan 29, 2026
Ex-Dividend Date	n/a

Share Statistics

BOM:530239 has 227.47 million shares outstanding. The number of shares has increased by 0.75% in one year.

Current Share Class	227.47M
Shares Outstanding	227.47M
Shares Change (YoY)	+0.75%
Shares Change (QoQ)	+1.77%
Owned by Insiders (%)	2.18%
Owned by Institutions (%)	28.63%
Float	n/a

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	517.97
PB Ratio	10.80
P/TBV Ratio	10.80
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-13.12
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-12.83

Financial Position

The company has a current ratio of 5.11

Current Ratio	5.11
Quick Ratio	4.77
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-27,684.51

Financial Efficiency

Return on equity (ROE) is -89.41% and return on invested capital (ROIC) is -593.05%.

Return on Equity (ROE)	-89.41%
Return on Assets (ROA)	-49.76%
Return on Invested Capital (ROIC)	-593.05%
Return on Capital Employed (ROCE)	-77.29%
Weighted Average Cost of Capital (WACC)	6.22%
Revenue Per Employee	424,841
Profits Per Employee	-15.35M
Employee Count	138
Asset Turnover	0.02
Inventory Turnover	1.59

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +5.07% in the last 52 weeks. The beta is 0.36, so BOM:530239's price volatility has been lower than the market average.

Beta (5Y)	0.36
52-Week Price Change	+5.07%
50-Day Moving Average	167.62
200-Day Moving Average	202.40
Relative Strength Index (RSI)	26.03
Average Volume (20 Days)	17,002

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, BOM:530239 had revenue of INR 58.63 million and -2.12 billion in losses. Loss per share was -9.63.

Revenue	58.63M
Gross Profit	51.12M
Operating Income	-2.19B
Pretax Income	-2.12B
Net Income	-2.12B
EBITDA	-2.13B
EBIT	-2.19B
Loss Per Share	-9.63

Balance Sheet

The company has 2.57 billion in cash and n/a in debt, with a net cash position of 2.57 billion or 11.32 per share.

Cash & Cash Equivalents	2.57B
Total Debt	n/a
Net Cash	2.57B
Net Cash Per Share	11.32
Equity (Book Value)	2.81B
Book Value Per Share	12.66
Working Capital	2.24B

Cash Flow

In the last 12 months, operating cash flow was -1.77 billion and capital expenditures -393.37 million, giving a free cash flow of -2.17 billion.

Operating Cash Flow	-1.77B
Capital Expenditures	-393.37M
Free Cash Flow	-2.17B
FCF Per Share	-9.52

Margins

Gross Margin	87.19%
Operating Margin	-3,730.43%
Pretax Margin	-3,614.11%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

BOM:530239 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.75%
Shareholder Yield	-0.75%
Earnings Yield	-6.98%
FCF Yield	-7.13%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on March 23, 2007. It was a forward split with a ratio of 4.

Last Split Date	Mar 23, 2007
Split Type	Forward
Split Ratio	4

Scores

Altman Z-Score	n/a
Piotroski F-Score	1